Invitro & Invivo Diagnostic

Aptamer Group and Neuro-Bio Adapt Saliva-Based Alzheimer’s Test to ELISA Format, Advancing Towards Commercialisation

The partnership aims to deliver a non-invasive, hospital-compatible diagnostic using Aptamer’s Optimer binders and Neuro-Bio’s novel early-stage biomarker, with commercial rollout targeted within 12–18 months....

AMDI Launches Autolab™ HBH System to Transform Sample Preparation in Under 2 Minutes

Unveiled at ESCMID Global Congress 2025, the new Hyperbaric Heating-based platform eliminates the need for extraction kits—delivering faster, simpler, and cost-effective molecular workflows across diverse research and diagnostic applications....

Immunovia’s Next-Gen Blood Test Outperforms CA19-9 in Detecting Early-Stage Pancreatic Cancer

New results from the VERIFI study show Immunovia's test accurately detects 77% of early-stage cases and maintains strong specificity across diverse high-risk groups—strengthening commercial launch plans for Q3 2025....

VolitionRx Unveils Promising Data: Nu.Q® Immunoassay Detects 21 Cancers, Eyes Multi-Licensing Deals

With low false positives and broad detection capabilities, Volition’s Nu.Q® test could reshape the $20B liquid biopsy market, as the company advances licensing talks with major diagnostic players. ...

Gene Bio Medical and Bidiphar Form Strategic Joint Venture to Advance Global Healthcare

Collaboration aims to enhance pharmaceutical innovation and expand access to high-quality healthcare solutions worldwide. ...

Beckman Coulter Secures FDA Clearance for DxC 500i Clinical Analyzer

The integrated clinical chemistry and immunoassay system enhances efficiency, streamlines lab workflows, and delivers accurate diagnostics in a compact design....

Co-Diagnostics, Inc. Secures Dismissal of Class-Action Lawsuit

Court ruling dismisses claims against Co-Diagnostics, reinforcing the company’s commitment to transparency and innovation in molecular diagnostics....

Sky Medical Technology Partners with SMS Medical to Distribute Geko™ Device for Post-Orthopedic Surgery Care in the U.S.

The agreement aims to expand access to Geko™, a non-invasive device designed to reduce edema, prevent DVT, and improve recovery after orthopedic procedures....

Sebelas Miudella™ Becomes First FDA-Approved Hormone-Free IUD in 40 Years

Offering a long-acting, non-hormonal birth control option, the approval marks a significant milestone in expanding contraceptive choices for individuals seeking hormone-free alternatives. ...

UK’s MYndspan Partners with MEGIN to Expand Access to High-Precision Brain Scans

Collaboration brings clinical-grade magnetoencephalography (MEG) technology to consumers, launching first brain health center in London....